Lupin logo

LUPIN - Lupin News Story

₹1232.4 35.9  3.0%

Last Trade - 5:15am

Sector
Healthcare
Size
Large Cap
Market Cap £5.31bn
Enterprise Value £5.52bn
Revenue £1.49bn
Position in Universe 81st / 3107

BRIEF-Lupin Gets ANDA Approval From U.S. FDA For Levothyroxine Sodium Tablets USP

Fri 20th September, 2019 12:21pm
Sept 20 (Reuters) - Lupin Ltd  LUPN.NS :
    * GETS ANDA APPROVAL FROM U.S. FDA FOR LEVOTHYROXINE SODIUM
TABLETS USP

Source text for Eikon:  ID:nBSE9lk0vw 
Further company coverage:  LUPN.NS 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.